Literature DB >> 10962183

Effects of chronic salicylate on GABAergic activity in rat inferior colliculus.

C A Bauer1, T J Brozoski, T M Holder, D M Caspary.   

Abstract

It is well accepted that salicylate ototoxicity results in reversible tinnitus in humans. Salicylate-induced tinnitus may be an example of plasticity of the central auditory system and could potentially serve as a model to further understand mechanisms of tinnitus generation. This study examined levels of glutamic acid decarboxylase (GAD) and the binding characteristics of the GABA(A) receptor in auditory brainstem structures of Long-Evans rats chronically treated with salicylate. Western blotting revealed a significant 63% (P<0.008) elevation of GAD levels in the inferior colliculus (IC) of salicylate-treated subjects. This occurred in subjects demonstrating behavioral evidence of tinnitus. Muscimol saturation analysis was indicative of a salicylate-related increase in receptor affinity. Linear regression of [(3)H]muscimol saturation analysis data revealed a significant (P<0.05) reduction in K(d) values in whole IC (-48%), as well as in the central nucleus of IC (CIC, -58%) and combined external and dorsal cortex of IC (E/DCIC, -46%). The number of GABA(A) binding sites (B(max)) were also significantly (P<0.05) decreased. These changes were observed only in central auditory structures. This suggests that GAD expression and GABA(A) receptor binding characteristics may be altered with chronic exposure to sodium salicylate and these changes may represent aberrant plasticity clinically experienced as tinnitus.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10962183     DOI: 10.1016/s0378-5955(00)00130-1

Source DB:  PubMed          Journal:  Hear Res        ISSN: 0378-5955            Impact factor:   3.208


  38 in total

1.  Deafness-related decreases in glycine-immunoreactive labeling in the rat cochlear nucleus.

Authors:  Mikiya Asako; Avril G Holt; Ronald D Griffith; Eric D Buras; Richard A Altschuler
Journal:  J Neurosci Res       Date:  2005-07-01       Impact factor: 4.164

2.  Vigabatrin, a GABA transaminase inhibitor, reversibly eliminates tinnitus in an animal model.

Authors:  Thomas J Brozoski; T Joseph D Spires; Carol A Bauer
Journal:  J Assoc Res Otolaryngol       Date:  2007-01-13

Review 3.  The role of central nervous system plasticity in tinnitus.

Authors:  James C Saunders
Journal:  J Commun Disord       Date:  2007-03-14       Impact factor: 2.288

4.  Up-regulation of Ca2+/CaMKII/CREB signaling in salicylate-induced tinnitus in rats.

Authors:  Jiuhan Zhao; Biao Wang; Xiaohong Wang; Xiuli Shang
Journal:  Mol Cell Biochem       Date:  2018-02-09       Impact factor: 3.396

5.  Plastic changes along auditory pathway during salicylate-induced ototoxicity: Hyperactivity and CF shifts.

Authors:  Chen Jiang; Bin Luo; Senthilvelan Manohar; Guang-Di Chen; Richard Salvi
Journal:  Hear Res       Date:  2016-10-27       Impact factor: 3.208

6.  PHARMACOLOGICAL TREATMENTS FOR TINNITUS: NEW AND OLD.

Authors:  R Salvi; E Lobarinas; W Sun
Journal:  Drugs Future       Date:  2009       Impact factor: 0.148

7.  Salicylate initiates apoptosis in the spiral ganglion neuron of guinea pig cochlea by activating caspase-3.

Authors:  Hao Feng; Shi-Hua Yin; An-Zhou Tang; Song-Hua Tan
Journal:  Neurochem Res       Date:  2011-03-31       Impact factor: 3.996

8.  Impact of ageing on postsynaptic neuronal nicotinic neurotransmission in auditory thalamus.

Authors:  Sarah Y Sottile; Lynne Ling; Brandon C Cox; Donald M Caspary
Journal:  J Physiol       Date:  2017-07-07       Impact factor: 5.182

Review 9.  Salicylate-induced cochlear impairments, cortical hyperactivity and re-tuning, and tinnitus.

Authors:  Guang-Di Chen; Daniel Stolzberg; Edward Lobarinas; Wei Sun; Dalian Ding; Richard Salvi
Journal:  Hear Res       Date:  2012-11-27       Impact factor: 3.208

Review 10.  [Functional and activity-dependent plasticity mechanisms in the adult and developing auditory brain].

Authors:  M A Izquierdo; D L Oliver; M S Malmierca
Journal:  Rev Neurol       Date:  2009 Apr 16-30       Impact factor: 0.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.